[Preclinical studies of pioglitazone (AD-4833)].
Sugiyama
Y
Y
Pharmaceutical Research Laboratories II, Takeda Chemical Industries.
Odaka
H
H
Sohda
T
T
Ikeda
H
H
D000818:Animals; D003920:Diabetes Mellitus / Q000188:drug therapy; D004195:Disease Models, Animal; D006003:Glycogen / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D007333:Insulin Resistance; D008099:Liver / Q000378:metabolism; D000077205:Pioglitazone; D013844:Thiazoles / Q000494:pharmacology* / Q000627:therapeutic use; D045162:Thiazolidinediones
D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D006003:Glycogen; D000077205:Pioglitazone